Intellipharmaceutics International Financials

Intellipharmaceutics Stock Summary

Intellipharmaceutics competes with Intelgenx Technologs. Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.

Intellipharmaceutics Key Financial Ratios

There are many critical financial ratios that Intellipharmaceutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Intellipharmaceutics reports annually and quarterly.

Intellipharmaceutics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Intellipharmaceutics's current stock value. Our valuation model uses many indicators to compare Intellipharmaceutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intellipharmaceutics competition to find correlations between indicators driving Intellipharmaceutics's intrinsic value. More Info.Intellipharmaceutics International is rated fifth overall in return on asset category among its peers. It also is rated fifth overall in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intellipharmaceutics' earnings, one of the primary drivers of an investment's value.

Intellipharmaceutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Intellipharmaceutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intellipharmaceutics International. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intellipharmaceutics International based on widely used predictive technical indicators. In general, we focus on analyzing Intellipharmaceutics OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intellipharmaceutics's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.